Located in Vienna, Ribbon Biolabs designs and manufactures InfiniSynth™, an automated platform for producing long, high-fidelity DNA constructs. Their enzyme-driven assembly system enables scientists and biotech firms to order custom gene fragments over 10 kb in just days—breaking previous length and accuracy limits.
Ribbon reduces R&D timelines for gene therapies, synthetic biology, and vaccine development. Supported by EU innovation grants and Series A funding, they recently celebrated the launch of a new production facility.
